Pulmonary Surfactant Formulations and Methods for Promoting Mucus Clearance
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application 61/616,827, filed Mar 28, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,221,772 | Pulmonary Surfactant Formulations and Methods for Promoting Mucus Clearance In force · High confidence | Windtree Therapeutics, Inc. | In force | High confidence | ||
| US 8,748,396 | Lyophilization of Synthetic Liposomal Pulmonary Surfactant In force · Medium confidence | Windtree Therapeutics, Inc. | In force | Medium confidence | ||
| US 8,748,397 | Lyophilization of Synthetic Liposomal Pulmonary Surfactant In force · Medium confidence | Windtree Therapeutics, Inc. | In force | Medium confidence | ||
| US 9,554,999 | Lyophilization of Synthetic Liposomal Pulmonary Surfactant In force · High confidence | Windtree Therapeutics, Inc. | In force | High confidence | ||
| US 8,337,815 | Pulmonary Surfactant Formulations Lapsed Dec 25, 2016 on the fee record Ended Dec 25, 2016 · High confidence | Windtree Therapeutics, Inc. | Lapsed Dec 25, 2016 on the fee record | Ended Dec 25, 2016 | High confidence | |
| US 7,582,312 | Methods to Produce Lung Surfactant Formulations via Lyophilization and Formulations and Uses Thereof Lapsed Sep 1, 2017 on the fee record Ended Sep 1, 2017 · High confidence | Windtree Therapeutics, Inc. | Lapsed Sep 1, 2017 on the fee record | Ended Sep 1, 2017 | High confidence | |
| US 7,541,331 | Surfactant Treatment Regimen Term ended Term ended Jan 6, 2026 · High confidence | Windtree Therapeutics, Inc. | Term ended | Term ended Jan 6, 2026 | High confidence |
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Windtree Therapeutics, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.